Sign in or Register   Sign in or Register
  |  

Mouse Anti-KRT19 Recombinant Antibody (2F3-G5-F3-H10-F6-E7) (CBMAB-K0206-LY)

This product is antibody recognizes KRT19. The antibody 2F3-G5-F3-H10-F6-E7 immunoassay techniques such as: ELISA, WB.
See all KRT19 antibodies

Summary

Host Animal
Mouse
Specificity
Human
Clone
2F3-G5-F3-H10-F6-E7
Antibody Isotype
IgM
Application
ELISA, WB

Basic Information

Immunogen
Recombinant protein. This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with the immunogen
Specificity
Human
Antibody Isotype
IgM
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Purity
> 95% Purity determined by SDS-PAGE.
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freezethaw cycles.

Target

Full Name
Keratin 19
Introduction
The protein encoded by this gene is a member of the keratin family. The keratins are intermediate filament proteins responsible for the structural integrity of epithelial cells and are subdivided into cytokeratins and hair keratins. The type I cytokeratins consist of acidic proteins which are arranged in pairs of heterotypic keratin chains. Unlike its related family members, this smallest known acidic cytokeratin is not paired with a basic cytokeratin in epithelial cells. It is specifically expressed in the periderm, the transiently superficial layer that envelopes the developing epidermis. The type I cytokeratins are clustered in a region of chromosome 17q12-q21. [provided by RefSeq, Jul 2008]
Entrez Gene ID
3880
UniProt ID
3880
Alternative Names
Keratin 19; 40-KDa Keratin Intermediate Filament; Keratin; Type I Cytoskeletal 19; Keratin; Type I; 40-Kd; Keratin 19; Type I; Cytokeratin 19; CK-19;
Function
Involved in the organization of myofibers. Together with KRT8, helps to link the contractile apparatus to dystrophin at the costameres of striated muscle.
Biological Process
Cell differentiation involved in embryonic placenta development Source: Ensembl
Cornification Source: Reactome
Keratinization Source: Reactome
Notch signaling pathway Source: Ensembl
Response to estrogen Source: UniProtKB
Sarcomere organization Source: UniProtKB
Viral process Source: UniProtKB-KW
Cellular Location
Intermediate filament; Terminal web; Cytosol; Extracellular exosome; Apicolateral plasma membrane; Dystrophin-associated glycoprotein complex; Plasma membrane; Sarcolemma; Cell periphery; Costamere; Z disc

Krüger, J., Fischer, A., Breunig, M., Allgöwer, C., Schulte, L., Merkle, J., ... & Kleger, A. (2023). DNA methylation‐associated allelic inactivation regulates Keratin 19 gene expression during pancreatic development and carcinogenesis. The Journal of Pathology, 261(2), 139-155.

Wang, Z., Moresco, P., Yan, R., Li, J., Gao, Y., Biasci, D., ... & Fearon, D. T. (2022). Carcinomas assemble a filamentous CXCL12–keratin-19 coating that suppresses T cell–mediated immune attack. Proceedings of the National Academy of Sciences, 119(4), e2119463119.

Alsharif, S., Sharma, P., Bursch, K., Milliken, R., Lam, V., Fallatah, A., ... & Chung, B. M. (2021). Keratin 19 maintains E-cadherin localization at the cell surface and stabilizes cell-cell adhesion of MCF7 cells. Cell adhesion & migration, 15(1), 1-17.

Rhee, H., Kim, H., & Park, Y. N. (2020). Clinico-radio-pathological and molecular features of hepatocellular carcinomas with keratin 19 expression. Liver Cancer, 9(6), 663-681.

Lam, V. K., Sharma, P., Nguyen, T., Nehmetallah, G., Raub, C. B., & Chung, B. M. (2020). Morphology, motility, and cytoskeletal architecture of breast cancer cells depend on keratin 19 and substrate. Cytometry Part A, 97(11), 1145-1155.

Yokomichi, N., Nishida, N., Umeda, Y., Taniguchi, F., Yasui, K., Toshima, T., ... & Nagasaka, T. (2019). Heterogeneity of epigenetic and epithelial mesenchymal transition marks in hepatocellular carcinoma with keratin 19 proficiency. Liver cancer, 8(4), 239-254.

Sharma, P., Alsharif, S., Bursch, K., Parvathaneni, S., Anastasakis, D. G., Chahine, J., ... & Chung, B. M. (2019). Keratin 19 regulates cell cycle pathway and sensitivity of breast cancer cells to CDK inhibitors. Scientific reports, 9(1), 14650.

Rhee, H., Kim, H. Y., Choi, J. H., Woo, H. G., Yoo, J. E., Nahm, J. H., ... & Park, Y. N. (2018). Keratin 19 expression in hepatocellular carcinoma is regulated by fibroblast-derived HGF via a MET-ERK1/2-AP1 and SP1 axis. Cancer research, 78(7), 1619-1631.

Palkó, E., Póliska, S., Sziklai, I., & Penyige, A. (2018). Analysis of KRT1, KRT10, KRT19, TP53 and MMP9 expression in pediatric and adult cholesteatoma. PLoS One, 13(7), e0200840.

Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-KRT19 Recombinant Antibody (2F3-G5-F3-H10-F6-E7)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare